NCT04854018View on ClinicalTrials.gov

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Pediatric Renal TumorMetastatic OsteosarcomaMetastatic Ewing SarcomaPulmonary MetastasisRhabdomyosarcomaNon-Rhabdo. Soft Tissue Sarcoma
Interventions
DRUG

Indocyanine green

Intravenous or intraparenchymal injection

Trial Locations (1)

B4 6NH

Birmingham children's hospital, Birmingham

All Listed Sponsors
lead

Birmingham Women's and Children's NHS Foundation Trust

OTHER